These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7448336)

  • 1. Biliary excretion of chlorthalidone in humans.
    Fleuren HL; Verwey-Van Wissen CP; Thien TA
    Biopharm Drug Dispos; 1980; 1(3):103-10. PubMed ID: 7448336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, metabolism and biliary and urinary excretion of oral ramipril in man.
    Verho M; Luck C; Stelter WJ; Rangoonwala B; Bender N
    Curr Med Res Opin; 1995; 13(5):264-73. PubMed ID: 7555035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.
    Fleuren HL; Thien TA; Verwey-van Wissen CP; van Rossum JM
    Eur J Clin Pharmacol; 1979 Feb; 15(1):35-50. PubMed ID: 421727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excretion of hydroflumethiazide in bile and urine of man.
    Brørs O; Haffner JF; Jacobsen S
    Eur J Clin Pharmacol; 1979 May; 15(4):287-9. PubMed ID: 477714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of cefixime biliary disposition in the isolated perfused rabbit liver model and in humans.
    Westphal JF; Brogard JM; Jehl F; Schloegel M; Blickle JF; Monteil H
    Drugs Exp Clin Res; 1992; 18(8):329-36. PubMed ID: 1292915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic profiles of montelukast sodium (Singulair), a potent cysteinyl leukotriene1 receptor antagonist, in human plasma and bile.
    Balani SK; Xu X; Pratha V; Koss MA; Amin RD; Dufresne C; Miller RR; Arison BH; Doss GA; Chiba M; Freeman A; Holland SD; Schwartz JI; Lasseter KC; Gertz BJ; Isenberg JI; Rogers JD; Lin JH; Baillie TA
    Drug Metab Dispos; 1997 Nov; 25(11):1282-7. PubMed ID: 9351905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of ciprofloxacine metabolites in its biliary and urinary elimination in man].
    Brogard JM; Jehl F; Blickle JF; Arnaud JP; Monteil H
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):719-23. PubMed ID: 3054754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary results of biliary excretion of ramipril after T-drainage in cholecystectomy patients.
    Luck C; Verho M; Umscheid T; Stelter WJ; Ziegler HP
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S116-21. PubMed ID: 1725018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary excretion and enterohepatic recirculation of practolol in man.
    Carruthers SG; Kelly JG; Johnson GW; McDevitt DG
    Ir J Med Sci; 1976 Dec; 145(1):187-94. PubMed ID: 27517227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatobiliary elimination of temafloxacin.
    Sörgel F; Granneman GR; Mahr G; Kujath P; Fabian W; Nickel P
    Clin Pharmacokinet; 1992; 22 Suppl 1():33-42. PubMed ID: 1319869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the distribution and elimination of haloperidol in cholecystectomized patients.
    Forsman A; Larsson M; Lundborg H; Renstrom P
    Eur J Drug Metab Pharmacokinet; 1981; 6(4):249-53. PubMed ID: 7333324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on digitalis. III. Biliary excretion and enterohepatic circulation of digitoxin and its cardioactive metabolites.
    Storstein L
    Clin Pharmacol Ther; 1975 Mar; 17(3):313-20. PubMed ID: 1120397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biliary excretion and hepatic disposal of cefixime: experimental and clinical study].
    Westphal JF; Brogard JM; Jehl F; Blickle JF; Dorner M; Monteil H
    Pathol Biol (Paris); 1992 May; 40(5):538-44. PubMed ID: 1495841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biliary secretion of methadone and methadone metabolites in man.
    Kreek MJ; Kalisman M; Irwin M; Jaffery NF; Scheflan M
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):67-78. PubMed ID: 7403680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
    Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
    J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary, biliary and faecal excretion of rocuronium in humans.
    Proost JH; Eriksson LI; Mirakhur RK; Roest G; Wierda JM
    Br J Anaesth; 2000 Nov; 85(5):717-23. PubMed ID: 11094587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biliary excretion and enterochepatic recycling of proscillaridin A after oral adminstration to man.
    Andersson KE; Bergdahl B; Wettrell G
    Eur J Clin Pharmacol; 1977 Apr; 11(4):273-6. PubMed ID: 862647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biliary excretion of cefaclor. Experimental and clinical study.
    Brogard JM; Pinget M; Comte F; Adloff M; Lavillaureix J
    Chemotherapy; 1982; 28(3):189-99. PubMed ID: 7094660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics, tissue distribution, and metabolism of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (NSC 707545) in CD2F1 mice and Fischer 344 rats.
    Egorin MJ; Lagattuta TF; Hamburger DR; Covey JM; White KD; Musser SM; Eiseman JL
    Cancer Chemother Pharmacol; 2002 Jan; 49(1):7-19. PubMed ID: 11855755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biliary and renal elimination of the new muscarinic-1-antagonist AWD 26-06 in volunteers with T-tube after cholecystectomy.
    Trausch B; Terhaag B; Gebhardt M; Richter K; Oertel R
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):508-9. PubMed ID: 1490811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.